DJIA 17,077.35 103.04 0.61%
NASDAQ 4,537.76 -11.47 -0.25%
S&P 500 1,981.01 -1.29 -0.07%
market minute promo

NxStage Medical (NASDAQ: NXTM)

15.06 -0.06 (-0.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NXTM $15.06 -0.40%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.06
Previous Close $15.12
Daily Range $14.93 - $15.28
52-Week Range $8.77 - $15.50
Market Cap $931.1M
P/E Ratio -47.25
Dividend (Yield) $0.00 (0.0%)
Volume 91,344
Average Daily Volume 296,329
Current FY EPS -$0.44




Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website:

News & Commentary Rss Feed

Is It Time to Buy These 4 Dialysis Stocks?

Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?

Commit To Purchase NxStage Medical At $12.50, Earn 14.1% Annualized Using Options

Lumenis: Shares In This Medical Device Maker Are Poised For Gains

Update: NxStage Medical Earnings

NxStage Medical's (NXTM) CEO Jeff Burbank on Q2 2014 Results - Earnings Call Transcript

Sector Update: Health Care

Sector Update: Health-Care Shares Higher Pre-Market

NxStage Medical (NXTM) Q2 2014 Results - Earnings Call Webcast

Mariel Therapeutics Acquires Stryker Assets - Analyst Blog

St. Jude Medical Hits New Lifetime High - Analyst Blog

Medtronic's MiniMed Insulin Pump: A Key to Type 2 Diabetes Cure - Analyst Blog

See More NXTM News...

NXTM's Top Competitors

NXTM $15.06 (-0.40%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $67.01 (-0.04%)
Current stock: MDT
COV $91.47 (-0.24%)
Current stock: COV